Form 4 for ACRV Acrivon Therapeutics, Inc.
Accepted 2025-02-19 00:00:00 ET · period of report 2025-02-14 · accession 0000905148-25-000726 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-19 | 2025-02-14 | ACRV | Devroe Eric | COO | F - Tax | $5.42 | -724 | 67.1K | -1% | -$3,924 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-14 | F | D | 724 | $5.42 | 67,147 | D | — | — |